Roles of miR-497 and its potential signaling pathway in diseases and with vascular endothelial growth factor

References

• Lindberg RL, Hoffmann F, Mehling M, et al. Altered expression of miR-17-5p in CD4 + lymphocytes of relapsing-remitting multiple sclerosis patients. Eur J Immunol 2010;40:888–98
   PubMed Web of Science ®Google Scholar
• Denby L, Ramdas V, McBride MW, et al. miR-21 and miR-214 are consistently modulated during renal injury in rodent models. Am J Pathol 2011;179:661–72
   PubMed Web of Science ®Google Scholar
• Chung AC, Yu X, Lan HY. MicroRNA and nephropathy: emerging concepts. Int J Nephrol Renovasc Dis 2013;6:169–79
   PubMedGoogle Scholar
• Feinmesser M, Benbassat C, Meiri E, et al. Specific microRNAs differentiate adrenocortical adenomas from carcinomas and correlate with weiss histopathologic system. Appl Immunohistochem Mol Morphol 2014. [Epub ahead of print]
   Google Scholar
• Flavin RJ, Smyth PC, Laios A, et al. Potentially important microRNA cluster on chromosome 17p13.1 in primary peritoneal carcinoma. Mod Pathol 2009;22:197–205
   PubMed Web of Science ®Google Scholar
• Crafts TD, Jensen AR, Blocher-Smith EC, et al. Vascular endothelial growth factor: therapeutic possibilities and challenges for the treatment of ischemia. Cytokine 2014. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Su CM, Su YH, Chiu CF, et al. Vascular endothelial growth factor-C upregulates cortactin and promotes metastasis of esophageal squamous cell carcinoma. Ann Surg Oncol 2014. [Epub ahead of print]
   Web of Science ®Google Scholar
• Zhao WY, Wang Y, An ZJ, et al. Downregulation of miR-497 promotes tumor growth and angiogenesis by targeting HDGF in non-small cell lung cancer. Biochem Biophys Res Commun 2013;435:466–71
   PubMed Web of Science ®Google Scholar
• Zhao ZZ, Cao Y, Liu ZS, et al. Effects of recombinant human endostatin on peritoneal angiogenesis in peritoneal dialysis rats. Nephrology (Carlton) 2011;16:599–606
   PubMed Web of Science ®Google Scholar
• Munoz A, Garrido-Gil P, Dominguez-Meijide A, et al. Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease. Involvement of vascular endothelial growth factor and interleukin-1beta. Exp Neurol 2014;261:720–32
   PubMed Web of Science ®Google Scholar
• Wang W, Ren F, Wu Q, et al. MicroRNA-497 inhibition of ovarian cancer cell migration and invasion through targeting of SMAD specific E3 ubiquitin protein ligase 1. Biochem Biophys Res Commun 2014;449:432–7
   PubMed Web of Science ®Google Scholar
• Wang W, Ren F, Wu Q, et al. MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer. Oncol Rep 2014. [Epub ahead of print]
   Web of Science ®Google Scholar
• Luo M, Shen D, Zhou X, et al. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor. Surgery 2013;153:836–47
   PubMed Web of Science ®Google Scholar
• Han J, Huo M, Mu M, et al. miR-497 suppresses proliferation of human cervical carcinoma HeLa cells by targeting cyclin E1. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2014;30:597–600
   PubMedGoogle Scholar
• Zheng D, Radziszewska A, Woo P. MicroRNA 497 modulates interleukin 1 signalling via the MAPK/ERK pathway. FEBS Lett 2012;586:4165–72
   PubMed Web of Science ®Google Scholar
• Wang S, Li H, Wang J, et al. Expression of microRNA-497 and its prognostic significance in human breast cancer. Diagn Pathol 2013;8:172
   PubMedGoogle Scholar
• Lehmann U, Streichert T, Otto B, et al. Identification of differentially expressed microRNAs in human male breast cancer. BMC Cancer 2010;10:109
   PubMed Web of Science ®Google Scholar
• Li D, Zhao Y, Liu C, et al. Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer. Clin Cancer Res 2011;17:1722–30
   PubMed Web of Science ®Google Scholar
• Shen L, Li J, Xu L, et al. miR-497 induces apoptosis of breast cancer cells by targeting Bcl-w. Exp Ther Med 2012;3:475–80
   PubMed Web of Science ®Google Scholar
• Luo Q, Li X, Gao Y, et al. MiRNA-497 regulates cell growth and invasion by targeting cyclin E1 in breast cancer. Cancer Cell Int 2013;13:95
   PubMedGoogle Scholar
• Xu JW, Wang TX, You L, et al. Insulin-like growth factor 1 receptor (IGF-1R) as a target of MiR-497 and plasma IGF-1R levels associated with TNM stage of pancreatic cancer. PLoS One 2014;9:e92847
   PubMed Web of Science ®Google Scholar
• Xu J, Wang T, Cao Z, et al. MiR-497 downregulation contributes to the malignancy of pancreatic cancer and associates with a poor prognosis. Oncotarget 2014;5:6983–93
   PubMed Web of Science ®Google Scholar
• Wang L, Li B, Li L, et al. MicroRNA-497 suppresses proliferation and induces apoptosis in prostate cancer cells. Asian Pac J Cancer Prev 2013;14:3499–502
   PubMed Web of Science ®Google Scholar
• Itesako T, Seki N, Yoshino H, et al. The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster. PLoS One 2014;9:e84311
   PubMed Web of Science ®Google Scholar
• Guo ST, Jiang CC, Wang GP, et al. MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer. Oncogene 2013;32:1910–20
   PubMed Web of Science ®Google Scholar
• Qiu YY, Hu Q, Tang QF, et al. MicroRNA-497 and bufalin act synergistically to inhibit colorectal cancer metastasis. Tumour Biol 2014;35:2599–606
   PubMed Web of Science ®Google Scholar
• Li W, Jin X, Deng X, et al. The putative tumor suppressor microRNA-497 modulates gastric cancer cell proliferation and invasion by repressing eIF4E. Biochem Biophys Res Commun 2014;449:235–40
   PubMed Web of Science ®Google Scholar
• Zhu W, Zhu D, Lu S, et al. miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2. Med Oncol 2012;29:384–91
   PubMed Web of Science ®Google Scholar
• Balatti V, Maniero S, Ferracin M, et al. MicroRNAs dysregulation in human malignant pleural mesothelioma. J Thorac Oncol 2011;6:844–51
   PubMed Web of Science ®Google Scholar
• Yang C, Wang C, Chen X, et al. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas. Int J Cancer 2013;132:116–27
   PubMed Web of Science ®Google Scholar
• Caramuta S, Lee L, Ozata DM, et al. Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma. Endocr Relat Cancer 2013;20:551–64
   PubMed Web of Science ®Google Scholar
• Xie Y, Wei RR, Huang GL, et al. Checkpoint kinase 1 is negatively regulated by miR-497 in hepatocellular carcinoma. Med Oncol 2014;31:844
   PubMed Web of Science ®Google Scholar
• Yin KJ, Deng Z, Huang H, et al. miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol Dis 2010;38:17–26
   PubMed Web of Science ®Google Scholar
• Yadav S, Pandey A, Shukla A, et al. miR-497 and miR-302b regulate ethanol-induced neuronal cell death through BCL2 protein and cyclin D2. J Biol Chem 2011;286:37347–57
   PubMed Web of Science ®Google Scholar
• Creevey L, Ryan J, Harvey H, et al. MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1. Mol Cancer 2013;12:23
   PubMedGoogle Scholar
• Li Z, Lu J, Luo Y, et al. High association between human circulating microRNA-497 and acute myocardial infarction. Scientific World J 2014;2014:931845
   Google Scholar
• Lan J, Xue Y, Chen H, et al. Hypoxia-induced miR-497 decreases glioma cell sensitivity to TMZ by inhibiting apoptosis. FEBS Lett 2014;588:3333–9
   PubMed Web of Science ®Google Scholar
• Shan Z, Yao C, Li ZL, et al. Differentially expressed microRNAs at different stages of atherosclerosis in ApoE-deficient mice. Chin Med J (Engl) 2013;126:515–20
   PubMed Web of Science ®Google Scholar
• Sato T, Yamamoto T, Sehara-Fujisawa A. miR-195/497 induce postnatal quiescence of skeletal muscle stem cells. Nat Commun 2014;5:4597
   PubMed Web of Science ®Google Scholar
• Wu L, Jiang Y, Zhu J, et al. Orosomucoid1: involved in vascular endothelial growth factor-induced blood-brain barrier leakage after ischemic stroke in mouse. Brain Res Bull 2014. [Epub ahead of print]
   Web of Science ®Google Scholar
• Gao D, Zhao ZZ, Liang XH, et al. Effect of peritoneal dialysis on expression of vascular endothelial growth factor, basic fibroblast growth factor and endostatin of the peritoneum in peritoneal dialysis patients. Nephrology (Carlton) 2011;16:736–42
   PubMed Web of Science ®Google Scholar